Yili Chuanning Biotechnology Co.,Ltd. (SHE: 301301)

Yili Chuanning Biotechnology Co.,Ltd. Statistics

Total Valuation

Yili Chuanning Biotechnology Co.,Ltd. has a market cap or net worth of CNY 30.45 billion. The enterprise value is 31.73 billion.

Market Cap	30.45B
Enterprise Value	31.73B

Important Dates

The last earnings date was Thursday, October 24, 2024.

Earnings Date	Oct 24, 2024
Ex-Dividend Date	May 22, 2024

Share Statistics

Yili Chuanning Biotechnology Co.,Ltd. has 2.23 billion shares outstanding. The number of shares has increased by 5.39% in one year.

Current Share Class	n/a
Shares Outstanding	2.23B
Shares Change (YoY)	+5.39%
Shares Change (QoQ)	-3.78%
Owned by Insiders (%)	0.07%
Owned by Institutions (%)	4.42%
Float	432.67M

Valuation Ratios

The trailing PE ratio is 22.50 and the forward PE ratio is 21.25.

PE Ratio	22.50
Forward PE	21.25
PS Ratio	5.43
PB Ratio	4.02
P/TBV Ratio	n/a
P/FCF Ratio	36.07
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

The stock's EV/EBITDA ratio is 14.28, with an EV/FCF ratio of 37.59.

EV / Earnings	23.05
EV / Sales	5.57
EV / EBITDA	14.28
EV / EBIT	18.95
EV / FCF	37.59

Financial Position

The company has a current ratio of 2.05, with a Debt / Equity ratio of 0.25.

Current Ratio	2.05
Quick Ratio	1.41
Debt / Equity	0.25
Debt / EBITDA	0.85
Debt / FCF	2.23
Interest Coverage	28.42

Financial Efficiency

Return on equity (ROE) is 19.31% and return on invested capital (ROIC) is 11.35%.

Return on Equity (ROE)	19.31%
Return on Assets (ROA)	10.16%
Return on Capital (ROIC)	11.35%
Revenue Per Employee	1.98M
Profits Per Employee	477,727
Employee Count	2,881
Asset Turnover	0.55
Inventory Turnover	4.17

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +70.50% in the last 52 weeks.

Beta (5Y)	n/a
52-Week Price Change	+70.50%
50-Day Moving Average	12.72
200-Day Moving Average	11.64
Relative Strength Index (RSI)	52.27
Average Volume (20 Days)	78,004,515

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Yili Chuanning Biotechnology Co.,Ltd. had revenue of CNY 5.70 billion and earned 1.38 billion in profits. Earnings per share was 0.61.

Revenue	5.70B
Gross Profit	2.00B
Operating Income	1.67B
Pretax Income	1.63B
Net Income	1.38B
EBITDA	2.22B
EBIT	1.67B
Earnings Per Share (EPS)	0.61

Balance Sheet

The company has 624.79 million in cash and 1.89 billion in debt, giving a net cash position of -1.26 billion or -0.57 per share.

Cash & Cash Equivalents	624.79M
Total Debt	1.89B
Net Cash	-1.26B
Net Cash Per Share	-0.57
Equity (Book Value)	7.59B
Book Value Per Share	3.40
Working Capital	2.09B

Cash Flow

In the last 12 months, operating cash flow was 1.06 billion and capital expenditures -220.98 million, giving a free cash flow of 843.99 million.

Operating Cash Flow	1.06B
Capital Expenditures	-220.98M
Free Cash Flow	843.99M
FCF Per Share	0.38

Margins

Gross margin is 35.18%, with operating and profit margins of 29.38% and 24.15%.

Gross Margin	35.18%
Operating Margin	29.38%
Pretax Margin	28.55%
Profit Margin	24.15%
EBITDA Margin	38.88%
EBIT Margin	29.38%
FCF Margin	14.81%

Dividends & Yields

This stock pays an annual dividend of 0.22, which amounts to a dividend yield of 1.59%.

Dividend Per Share	0.22
Dividend Yield	1.59%
Dividend Growth (YoY)	n/a
Years of Dividend Growth	1
Payout Ratio	40.18%
Buyback Yield	-5.39%
Shareholder Yield	-3.80%
Earnings Yield	4.45%
FCF Yield	2.77%

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Yili Chuanning Biotechnology Co.,Ltd. has an Altman Z-Score of 6.33.

Altman Z-Score	6.33
Piotroski F-Score	n/a